Viewing Study NCT02085603


Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2026-01-17 @ 12:12 PM
Study NCT ID: NCT02085603
Status: COMPLETED
Last Update Posted: 2018-04-13
First Post: 2014-03-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module